The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- National Rail Tentative Agreement Update: Q&As Complete, Voting Set to Begin
- From Skeptic to Supporter: Members Work Across the Aisle to Tackle Rail Safety
- Two Training Tracks Are FULL for Upcoming Atlanta Regional Meeting
- How Does a Government Shutdown Impact the Offices Members Rely On?
- The Truth From Within: General Chairpersons From CSX Statement on Departure of CEO Joe Hinrichs
- Update on National Rail Contract –Make Sure You Get Your Ballot
- Two RRB Field Offices Move to New Locations
- Reactions to the SMART-TD Guarantee with Union Pacific
- SMART-TD Members: Scholarships Available for You and Your Families
- President Ferguson Meets with SMART-TD Members at 3rd Annual Carolina Solidarity Shoot